Finerenone in Patients Undergoing TAVR for Nonrheumatic Aortic Stenosis: Insights From a Real-World Cohort
Open Access
- 30 October 2025
- journal article
- Published by Elsevier in Structural Heart
- Vol. 10 (3) , 100751
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- The role of finerenone in the concomitant management of chronic kidney disease-type 2 diabetes and the implication for heart failure prevention and treatmentHeart Failure Reviews, 2025
- Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection FractionNew England Journal of Medicine, 2024
- Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD TrialCirculation, 2022
- Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 DiabetesNew England Journal of Medicine, 2020